Holen Sie sich die Stockscreener-App
1.52
2.56%
-0.04
Handel nachbörslich:
1.52
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
Pacific Biosciences of California unveils HiFi sequencing for comprehensive multiomic analysis - Traders Union
PacbBio Announces Appointment of Christopher Gibson to Board of Directors and Member of the Science and Technology Committee, Effective March 3, 2026 - marketscreener.com
PacBio Adds AI-Driven Drug Discovery Leader to Board - TipRanks
Pacbio announces the appointment of Chris Gibson to the board of directors - marketscreener.com
AI drug discovery founder from Recursion joins PacBio board - Stock Titan
Pacific Biosciences of California, Inc. $PACB Shares Sold by ARK Investment Management LLC - MarketBeat
Farmer Michele sells Pacific Biosciences (PACB) shares for $4510 By Investing.com - Investing.com Canada
Farmer Michele sells Pacific Biosciences (PACB) shares for $4510 - Investing.com India
Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 12,497 Shares - MarketBeat
PRISM 2026 set to shape genomics future, Pacific Biosciences of California asserts - Traders Union
PACB,TAL Volatility & Greeks - Finviz
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Finviz
Intuitive Surgical Expands Direct Operational Presence in Europe - Finviz
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) - Finviz
Equity awards to Pacific Biosciences (PACB) officer disclosed - Stock Titan
PACB (PACB) grants James R. Gibson II 667,696 options and 333,848 RSUs - Stock Titan
Pacific Biosciences (PACB) officer receives large option and RSU awards - Stock Titan
Large equity grants to PacBio (PACB) executive highlight retention focus - Stock Titan
Christian Henry sells 472,667 PACB shares (PACB) on Form 144 - Stock Titan
PacBio and DNAstack Join Forces to Launch Worldwide HiFi Genome Network Hub - Bitget
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub - Yahoo Finance
Pacific Biosciences of California enables automatic epigenetic data in HiFi sequencing runs - Traders Union
Pacific Biosciences of California backs San Diego event to strengthen rare disease awareness - Traders Union
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know - Finviz
PACB,TAL Revenue Breakdown - Finviz
Pacific Biosciences of California joins IRDiRC to advance rare disease research - Traders Union
Vestmark Advisory Solutions Inc. Sells 692,663 Shares of Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Pacific Biosciences of California (PACB) Stock Analysis: A 53% Upside Awaits in the Genomic Sequencing Arena - DirectorsTalk Interviews
Pacific Biosciences Of California Files For Mixed Shelf Size - TradingView
[10-K] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files Annual Report | PACB SEC FilingForm 10-K - Stock Titan
Why Is PacBio (PACB) Stock Soaring Today - Yahoo Finance
PacBio (PACB) Joins Forces with DNAstack for Global Genomic Data Collaboration - GuruFocus
Volume Recap: Is Pacific Biosciences of California Inc stock a buy or sell2025 Winners & Losers & Free Reliable Trade Execution Plans - baoquankhu1.vn
PacBio and DNAstack launch first global federated HiFi whole genome dataset to accelerate rare disease research - marketscreener.com
Global genome network to speed answers for rare disease patients - Stock Titan
Pacific Biosciences of California examines technology impact on DNA sequencing insights - Traders Union
Pacific Biosciences COO Sells Shares - Intellectia AI
Why The PacBio (PACB) Narrative Is Shifting Around Fair Value And Long Read Sequencing - Yahoo Finance
Pacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by Zacks Research - MarketBeat
Will Pacific Biosciences of California Inc. outperform tech stocksMarket Movers & Weekly Stock Performance Updates - mfd.ru
Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 331,793 Shares - MarketBeat
Van Oene Mark sells PACB shares worth $294,318 By Investing.com - Investing.com Canada
Farmer of Pacific Biosciences sells $79,855 in stock By Investing.com - Investing.com South Africa
Van Oene Mark sells PACB shares worth $294,318 - Investing.com
Farmer of Pacific Biosciences sells $79,855 in stock - Investing.com
5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call - Finviz
PacBio (PACB) Q4 2025 Earnings Call Transcript - AOL.com
PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? - Finviz
PacBio stock up on HiFi sequencing adoption for major SUDC research - MSN
PacBio leaders set for TD Cowen health conference webcast - Stock Titan
Pacific Biosciences of California : PACB Q4 2025 Earning Prepared Remarks - marketscreener.com
Exit Recap: Should I invest in Clene Inc before earningsEarnings Risk Summary & Stepwise Swing Trade Plans - baoquankhu1.vn
Pacific Biosciences Faces Turbulent Market Amid Industry Shifts - timothysykes.com
Shareholder plans 606,312 PACB (NASDAQ: PACB) share sale - Stock Titan
Aug Drivers: Will Pacific Biosciences of California Inc outperform tech stocks2025 EndofYear Setup & Free Community Consensus Stock Picks - baoquankhu1.vn
Is Pacific Biosciences of California Inc. stock a falling knife or bargain buy2025 Stock Rankings & Long Hold Capital Preservation Tips - mfd.ru
How does Pacific Biosciences of California Inc. compare to its peersJuly 2025 Short Interest & Risk Managed Investment Signals - mfd.ru
Pacific Biosciences of California (PACB) reports Q4 loss, beats revenue estimates - MSN
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2025 Earnings Call Transcript - Insider Monkey
Slammed 28% Pacific Biosciences of California, Inc. (NASDAQ:PACB) Screens Well Here But There Might Be A Catch - 富途牛牛
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 6.8%What's Next? - MarketBeat
Pacific Biosciences of California: Navigating Market Waves Amid Revenue Hurdles - StocksToTrade
2.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):